Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test.

Progress in neuro-psychopharmacology & biological psychiatry 20121001

The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study.

Journal of clinical psychopharmacology 20121001

The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.

Addiction biology 20120901

The cost-effectiveness of tailored, postal feedback on general practitioners' prescribing of pharmacotherapies for alcohol dependence.

Drug and alcohol dependence 20120801

Trajectory analyses in alcohol treatment research.

Alcoholism, clinical and experimental research 20120801

Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence.

Recent patents on CNS drug discovery 20120801

Novel medication targets for the treatment of alcoholism: preclinical studies.

Recent patents on CNS drug discovery 20120801

Introduction to the special issue 'Pharmacotherapies for the treatment of alcohol abuse and dependence' and a summary of patents targeting other neurotransmitter systems.

Recent patents on CNS drug discovery 20120801

Does session attendance by a supportive significant other predict outcomes in individual treatment for alcohol use disorders?

Alcoholism, clinical and experimental research 20120701

Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.

Psychiatric services (Washington, D.C.) 20120701

Pharmacotherapy for adolescent alcohol use disorder.

CNS drugs 20120701

Commentary on the study: impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate (Prisciandaro et al.).

Alcoholism, clinical and experimental research 20120601

Pharmacogenetically driven treatments for alcoholism: are we there yet?

CNS drugs 20120601

Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.

Neuropharmacology 20120601

Strategies for evaluating the economic value of drugs in alcohol dependence treatment.

Drug and alcohol dependence 20120501

Influence of ionization source design on matrix effects during LC-ESI-MS/MS analysis.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120415

Alcoholic liver disease.

World journal of hepatology 20120327

Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.

Alcoholism, clinical and experimental research 20120301

Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.

Alcohol (Fayetteville, N.Y.) 20120301

Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.

Alcoholism, clinical and experimental research 20120301

Glutamatergic medications for the treatment of drug and behavioral addictions.

Pharmacology, biochemistry, and behavior 20120201

Acamprosate modulates experimental autoimmune encephalomyelitis.

Inflammopharmacology 20120201

A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.

Bipolar disorders 20120201

Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy.

Alcohol and alcoholism (Oxford, Oxfordshire) 20120101

Pharmacogenetics of alcoholism: a clinical neuroscience perspective.

Pharmacogenomics 20120101

The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.

PLoS medicine 20120101

Tinnitus.

BMJ clinical evidence 20120101

Role of acamprosate in sensorineural tinnitus.

Indian journal of pharmacology 20120101

Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.

Therapeutics and clinical risk management 20120101

Anti-Alcohol and Anxiolytic Properties of a New Chemical Entity, GET73.

Frontiers in psychiatry 20120101

Cost-effectiveness of peer-delivered interventions for cocaine and alcohol abuse among women: a randomized controlled trial.

PloS one 20120101

Do placebo response rates from cessation trials inform on strength of addictions?

International journal of environmental research and public health 20120101

Dihydrocodeine/Agonists for alcohol dependents.

Frontiers in psychiatry 20120101

Influence of cue exposure on inhibitory control and brain activation in patients with alcohol dependence.

Frontiers in human neuroscience 20120101

Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders.

Neural plasticity 20120101

Exercise and physical activity in the therapy of substance use disorders.

TheScientificWorldJournal 20120101

Deep brain stimulation of nucleus accumbens region in alcoholism affects reward processing.

PloS one 20120101

Pharmacological management of binge eating disorder: current and emerging treatment options.

Therapeutics and clinical risk management 20120101

Treatments for alcohol-related disorders in China: a developing story.

Alcohol and alcoholism (Oxford, Oxfordshire) 20120101

Long-lasting alterations in membrane properties, k(+) currents, and glutamatergic synaptic currents of nucleus accumbens medium spiny neurons in a rat model of alcohol dependence.

Frontiers in neuroscience 20120101

Electroacupuncture decreases excessive alcohol consumption involving reduction of FosB/ΔFosB levels in reward-related brain regions.

PloS one 20120101

Prognostic factors during outpatient treatment for alcohol dependence: cohort study with 6 months of treatment follow-up.

Alcohol and alcoholism (Oxford, Oxfordshire) 20120101

An open-label naturalistic pilot study of acamprosate in youth with autistic disorder.

Journal of child and adolescent psychopharmacology 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Calcium acamprosate: a triclinic polymorph.

Acta crystallographica. Section E, Structure reports online 20111201

[Current strategies for treatment of alcohol problems].

La Revue du praticien 20111201

[Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].

Ugeskrift for laeger 20111128

Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence.

Drug and alcohol dependence 20111101

The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.

Drug and alcohol dependence 20111101

Synaptic and morphological neuroadaptations in the putamen associated with long-term, relapsing alcohol drinking in primates.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20111101

Tryptophan in alcoholism treatment I: kynurenine metabolites inhibit the rat liver mitochondrial low Km aldehyde dehydrogenase activity, elevate blood acetaldehyde concentration and induce aversion to alcohol.

Alcohol and alcoholism (Oxford, Oxfordshire) 20111101

Opioid antagonists for the treatment of alcohol dependence.

American family physician 20111101

[Baclofen for alcohol addiction].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20111101

An open-label trial of acamprosate in the treatment of pathological gambling.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20111101

Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations.

PLoS medicine 20111101

Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.

The pharmacogenomics journal 20111001

A LC-MS analysis of acamprosate from human plasma: pharmacokinetic application.

Drug testing and analysis 20111001

Acamprosate-responsive brain sites for suppression of ethanol intake and preference.

American journal of physiology. Regulatory, integrative and comparative physiology 20111001

The mGluR5 antagonist MPEP elevates accumbal dopamine and glycine levels; interaction with strychnine-sensitive glycine receptors.

Addiction biology 20111001

Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scale.

Therapeutic drug monitoring 20111001

Circadian and acamprosate modulation of elevated ethanol drinking in mPer2 clock gene mutant mice.

Chronobiology international 20111001

[Good effect of drug therapy against alcoholism].

Lakartidningen 20111001

Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial.

Psychiatry research 20110815

A literature review of cost-benefit analyses for the treatment of alcohol dependence.

International journal of environmental research and public health 20110801

Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.

The Journal of nervous and mental disease 20110701

How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatment.

Neurophysiologie clinique = Clinical neurophysiology 20110701

Long-term γ-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics.

International journal of environmental research and public health 20110701

The case for considering quality of life in addiction research and clinical practice.

Addiction science & clinical practice 20110701

Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.

Addictive behaviors 20110601

Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence.

Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 20110601

Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.

Behavioural pharmacology 20110601

Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.

The American journal of managed care 20110601

Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization.

The American journal of managed care 20110601

Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110501

Marked reduction of heavy drinking did not reduce nicotine use over 1 year in a clinical sample of alcohol-dependent patients.

Pharmacopsychiatry 20110501

Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA.

Drug and alcohol dependence 20110401

A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.

Addictive behaviors 20110301

Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.

Alcoholism, clinical and experimental research 20110301

Addiction treatment: level of care determination.

Primary care 20110301

Effectiveness of acamprosate in the treatment of alcohol dependence.

American family physician 20110301

Mammalian molecular clocks.

Experimental neurobiology 20110301

Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1.

Neuroscience letters 20110225

Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence.

Journal of consulting and clinical psychology 20110201

Acamprosate reduces risk of return to drinking after detoxification, but is similarly effective to naltrexone.

Evidence-based mental health 20110201

ACP Journal Club. Review: Acamprosate increases abstinence in patients with alcohol dependence.

Annals of internal medicine 20110118

Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial.

The International journal of eating disorders 20110101

Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.

Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment.

Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

Does family history of alcoholism moderate naltrexone's effects on alcohol use?

Journal of studies on alcohol and drugs 20110101

Status of disulfiram in present day alcoholic deaddiction therapy.

Indian journal of psychiatry 20110101

GABAergic and glutamatergic modulation in binge eating: therapeutic approach.

Current pharmaceutical design 20110101

New trends in tinnitus management.

The open neurology journal 20110101

A role for accumbal glycine receptors in modulation of dopamine release by the glycine transporter-1 inhibitor org25935.

Frontiers in psychiatry 20110101

Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile.

BMC psychiatry 20110101

Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.

Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

Predictive value of obsessive-compulsive drinking scale (OCDS) for outcome in alcohol-dependent inpatients: results of a 24-month follow-up study.

Substance abuse treatment, prevention, and policy 20110101

Acamprosate and Baclofen were Not Effective in the Treatment of Pathological Gambling: Preliminary Blind Rater Comparison Study.

Frontiers in psychiatry 20110101

Pharmacological treatment of insomnia in alcohol recovery: a systematic review.

Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

Relapse prevention for addictive behaviors.

Substance abuse treatment, prevention, and policy 20110101

Modeling the cost-effectiveness of health care systems for alcohol use disorders: how implementation of eHealth interventions improves cost-effectiveness.

Journal of medical Internet research 20110101

Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the Netherlands.

BMC psychiatry 20110101

Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors.

BMC pharmacology 20110101

Treatment of decompensated alcoholic liver disease.

International journal of hepatology 20110101

Diabetes and psychiatric disorders.

Indian journal of endocrinology and metabolism 20110101

Alpe adria report 2010 - conclusions and recommendations for the treatment of alcohol dependence.

Frontiers in psychiatry 20110101

Neurosteroid Binding Sites on the GABA(A) Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence.

Advances in pharmacological sciences 20110101

HOMER: a human organ-specific molecular electronic repository.

BMC bioinformatics 20110101

Alternative splicing of AMPA subunits in prefrontal cortical fields of cynomolgus monkeys following chronic ethanol self-administration.

Frontiers in psychiatry 20110101

Medical treatment of alcohol dependence: a systematic review.

International journal of psychiatry in medicine 20110101

[Cochrane review about the effect of acamprosate].

Ugeskrift for laeger 20101206

Emerging drugs to treat alcoholism.

Expert opinion on emerging drugs 20101201

Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.

Alcoholism, clinical and experimental research 20101201

Acamprosate calcium as augmentation therapy for anxiety disorders.

The Annals of pharmacotherapy 20101201

Cost evaluation of evidence-based treatments.

Addiction science & clinical practice 20101201

Brief report: acamprosate in fragile X syndrome.

Journal of autism and developmental disorders 20101101

Network support as a prognostic indicator of drinking outcomes: the COMBINE Study.

Journal of studies on alcohol and drugs 20101101

Individualised treatment in alcohol-dependent patients.

European archives of psychiatry and clinical neuroscience 20101101

[The role of the glutamatergic system in the pathogenesis and treatment of alcohol dependence].

Postepy higieny i medycyny doswiadczalnej (Online) 20101025

Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats.

Biological psychiatry 20101015

Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.

Archives of general psychiatry 20101004

Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence.

Journal of substance abuse treatment 20101001

Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Alcoholism, clinical and experimental research 20101001

Acamprosate for alcohol dependence.

The Cochrane database of systematic reviews 20100908

Acamprosate modulates alcohol-induced hippocampal NMDA receptors and brain microsomal Ca2+-ATPase but induces oxidative stress in rat.

The Journal of membrane biology 20100901

Gambling on acamprosate: a case report.

The Journal of clinical psychiatry 20100901

Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers.

Therapeutic drug monitoring 20100801

The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study.

Medical care 20100501

Molecular basis and current treatment for alcoholic liver disease.

International journal of environmental research and public health 20100501

The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation.

Journal of substance abuse treatment 20100401

Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective.

Medical care 20100401

Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.

Psychiatric services (Washington, D.C.) 20100401

Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study.

Drug and alcohol dependence 20100301

Acamprosate.

Expert opinion on drug metabolism & toxicology 20100301

The clock gene PER2 and sleep problems: association with alcohol consumption among Swedish adolescents.

Upsala journal of medical sciences 20100301

Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.

CNS & neurological disorders drug targets 20100301

Pharmacotherapies for alcoholism: the old and the new.

CNS & neurological disorders drug targets 20100301

Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate.

Alcoholism, clinical and experimental research 20100101

Glycine receptors involved in acamprosate's modulation of accumbal dopamine levels: an in vivo microdialysis study.

Alcoholism, clinical and experimental research 20100101

The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.

Expert opinion on drug safety 20100101

Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.

Current opinion in investigational drugs (London, England : 2000) 20100101

The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy.

The American journal on addictions 20100101

Identification of molecular targets associated with ethanol toxicity and implications in drug development.

Current pharmaceutical design 20100101

Internal medicine residency training for unhealthy alcohol and other drug use: recommendations for curriculum design.

BMC medical education 20100101

Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.

Alcohol and alcoholism (Oxford, Oxfordshire) 20100101

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism.

Neuropsychiatric disease and treatment 20100101

Providing competency-based family medicine residency training in substance abuse in the new millennium: a model curriculum.

BMC medical education 20100101

Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy.

Current pharmaceutical design 20100101

Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment.

Current pharmaceutical design 20100101

The scope of costs in alcohol studies: Cost-of-illness studies differ from economic evaluations.

Cost effectiveness and resource allocation : C/E 20100101

[Impact of functional social support for abstinence after inpatient detoxification].

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20100101

Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.

Neuropsychiatric disease and treatment 20100101

[Update on current care guidelines: treatment of alcohol abuse].

Duodecim; laaketieteellinen aikakauskirja 20100101

Retrospective review of acute acamprosate exposures to a poison control system.

The American journal on addictions 20100101

Clinical predictors of outcome from an Australian pharmacological relapse prevention trial.

Alcohol and alcoholism (Oxford, Oxfordshire) 20100101

The pharmacotherapy of alcohol dependence: a state of the art review.

Mens sana monographs 20100101

Comparison of healthcare utilization among patients treated with alcoholism medications.

The American journal of managed care 20100101

Reduction by the Positive Allosteric Modulator of the GABA(B) Receptor, GS39783, of Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats Exposed to the 'Sipper' Procedure.

Frontiers in psychiatry 20100101

The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study.

Frontiers in psychiatry 20100101

Substance use and addiction research in India.

Indian journal of psychiatry 20100101

The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin.

Brain research 20091211

Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.

Drug and alcohol dependence 20091201

Packages of care for alcohol use disorders in low- and middle-income countries.

PLoS medicine 20091001

Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.

Prescrire international 20091001

Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study.

Alcoholism, clinical and experimental research 20090901

[Addiction in DSM V and ICD-11 state of the art].

Fortschritte der Neurologie-Psychiatrie 20090901

Effects of nicotine and illicit substance use on alcoholism treatment outcomes and acamprosate efficacy.

Journal of addiction medicine 20090901

Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring rats.

Alcoholism, clinical and experimental research 20090801

Cue-induced alcohol-seeking behaviour is reduced by disrupting the reconsolidation of alcohol-related memories.

Psychopharmacology 20090801

The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial.

Psychopharmacology 20090701

Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.

Addiction biology 20090701

[Interaction between Saint Johns Wort and alcohol deterrents?].

Lakartidningen 20090701

Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats.

Psychopharmacology 20090601

[Pharmacotherapy of substance dependence and withdrawal syndromes].

Therapeutische Umschau. Revue therapeutique 20090601

Treatment of alcohol dependence.

The Ceylon medical journal 20090601

Meta-analyses of placebo-controlled trials of acamprosate for the treatment of alcohol dependence: impact of the combined pharmacotherapies and behavior interventions study.

Journal of addiction medicine 20090601

Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.

British journal of cancer 20090505

The implications of medication development in the treatment of substance use disorders in developing countries.

Current opinion in psychiatry 20090501

Management of alcoholic liver disease.

Clinics in liver disease 20090501

Review of topiramate: an antiepileptic for the treatment of alcohol dependence.

Current drug abuse reviews 20090501

Sample bias from different recruitment strategies in a randomised controlled trial for alcohol dependence.

Drug and alcohol review 20090501

Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.

Alcoholism, clinical and experimental research 20090401

Tinnitus: characteristics, causes, mechanisms, and treatments.

Journal of clinical neurology (Seoul, Korea) 20090301

Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.

Drug and alcohol dependence 20090101

The state of pharmacotherapy for the treatment of alcohol dependence.

Journal of substance abuse treatment 20090101

Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.

Psychotherapy and psychosomatics 20090101

Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.

Addictive behaviors 20090101

Socioeconomic status and survival of cirrhosis patients: a Danish nationwide cohort study.

BMC gastroenterology 20090101

Determinants of improvement in quality of life of alcohol-dependent patients during an inpatient withdrawal programme.

International journal of medical sciences 20090101

A chemogenomics view on protein-ligand spaces.

BMC bioinformatics 20090101

Counteracting incentive sensitization in severe alcohol dependence using deep brain stimulation of the nucleus accumbens: clinical and basic science aspects.

Frontiers in human neuroscience 20090101

Open-label trial of acamprosate as a treatment for anxiety.

Primary care companion to the Journal of clinical psychiatry 20090101

Pharmacokinetics of acamprosate calcium in healthy Chinese subjects after oral administration of three dosage levels.

Arzneimittel-Forschung 20090101

Impulse control disorders in Parkinson's disease.

F1000 medicine reports 20090101

Tinnitus.

BMJ clinical evidence 20090101

Successful acamprosate treatment of alcohol dependence in schizophrenia.

Schizophrenia research 20081201

The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.

European journal of pharmacology 20081119

Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20081101

Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice.

Alcoholism, clinical and experimental research 20081101

Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.

Journal of studies on alcohol and drugs 20081101

Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.

Current drug abuse reviews 20081101

Introduction. The neurobiology of drug addiction: new vistas.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20081012

Effects of naltrexone and acamprosate on alcohol-induced NGFI-A expression in mouse brain.

Neurochemical research 20081001

Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats.

Alcoholism, clinical and experimental research 20081001

Preserved DNA from past clinical trials yields new information about a subtype of alcoholism.

Current psychiatry reports 20081001

Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.

Archives of general psychiatry 20081001

Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice.

Physiology & behavior 20080903

Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.

The international journal of neuropsychopharmacology 20080901

Relationship between medication adherence and treatment outcomes: the COMBINE study.

Alcoholism, clinical and experimental research 20080901

An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care.

Annals of family medicine 20080901

Aminomethylpiperazines as selective urotensin antagonists.

Bioorganic & medicinal chemistry letters 20080815

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.

Progress in neuro-psychopharmacology & biological psychiatry 20080801

Analysis of acamprosate in beagle dog plasma by LC-MS-MS.

Archives of pharmacal research 20080801

Acamprosate: recent findings and future research directions.

Alcoholism, clinical and experimental research 20080701

Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

Addiction (Abingdon, England) 20080601

Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets.

Archives of pharmacal research 20080601

The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Current neuropharmacology 20080601

[Pharmacotherapy of alcohol dependence].

MMW Fortschritte der Medizin 20080519

[Alcohol dependence: diagnosis and treatment].

La Revue de medecine interne 20080401

Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.

Addiction biology 20080301

The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.

Drug and alcohol dependence 20080301

Drugs for relapse prevention of alcoholism: ten years of progress.

Trends in pharmacological sciences 20080301

A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration.

Addiction biology 20080301

Alcohol related changes in regulation of NMDA receptor functions.

Current neuropharmacology 20080301

Pharmacodynamics of memantine: an update.

Current neuropharmacology 20080301

Acamprosate: safety and tolerability in the treatment of alcohol dependence.

Journal of addiction medicine 20080301

Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference.

Neuroscience letters 20080206

Effects of acamprosate on neuronal receptors and ion channels expressed in Xenopus oocytes.

Alcoholism, clinical and experimental research 20080201

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

Archives of general psychiatry 20080201

[Unhealthy alcohol use in the elderly--current screening and treatment strategies].

Fortschritte der Neurologie-Psychiatrie 20080201

From the neurobiologic basis of alcohol dependency to pharmacologic treatment strategies: bridging the knowledge gap.

Southern medical journal 20080201

Substance abuse and schizophrenia: pharmacotherapeutic intervention.

Journal of substance abuse treatment 20080101

[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Der Nervenarzt 20080101

Glutamatergic substrates of drug addiction and alcoholism.

Biochemical pharmacology 20080101

Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Biochemical pharmacology 20080101

A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.

Alcohol and alcoholism (Oxford, Oxfordshire) 20080101

NMDA receptor blockade: a novel avenue for tobacco intervention?

Medical hypotheses 20080101

Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

Journal of studies on alcohol and drugs 20080101

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.

Journal of psychopharmacology (Oxford, England) 20080101

Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.

The American journal on addictions 20080101

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20080101

Neurobiology and treatment in alcoholism--recent findings regarding Lesch's typology of alcohol dependence.

Alcohol and alcoholism (Oxford, Oxfordshire) 20080101

Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians.

BMC medical genetics 20080101

[Pharmacological review of alcoholic dependence treatment].

Vertex (Buenos Aires, Argentina) 20080101

State policy influence on the early diffusion of buprenorphine in community treatment programs.

Substance abuse treatment, prevention, and policy 20080101

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.

The American journal of drug and alcohol abuse 20080101

Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.

Substance abuse treatment, prevention, and policy 20080101

Effectiveness of sequential combined treatment in comparison with treatment as usual in preventing relapse in alcohol dependence.

Alcohol and alcoholism (Oxford, Oxfordshire) 20080101

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.

Theoretical biology & medical modelling 20080101

[Recent results in relaps prevention of alcoholism with Disulfiram].

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20080101

Inhalant abuse: A clinic-based study.

Indian journal of psychiatry 20080101

Agenda for specialty section in addiction medicine.

Indian journal of psychiatry 20080101

New therapies for alcohol dependence open options for office-based treatment.

JAMA 20071205

Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats.

Psychopharmacology 20071201

Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism.

Dialogues in clinical neuroscience 20071201

Therapeutic options and challenges for substances of abuse.

Dialogues in clinical neuroscience 20071201

Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.

Expert review of neurotherapeutics 20071101

Naltrexone long-acting formulation in the treatment of alcohol dependence.

Therapeutics and clinical risk management 20071001

The psychiatric management of patients with alcohol dependence.

Current treatment options in neurology 20070901

Acamprosate in alcohol dependence: implications of a unique mechanism of action.

Journal of addiction medicine 20070901

Psychometrics of the Drinker Inventory of Consequences (DrInC).

Addictive behaviors 20070801

Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.

The Journal of pharmacology and experimental therapeutics 20070801

Tinnitus.

BMJ clinical evidence 20070801

The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070701

The treatment of alcohol dependence.

Current opinion in psychiatry 20070501

Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal.

Alcoholism, clinical and experimental research 20070401

Acamprosate and primitive reflexes.

The Annals of pharmacotherapy 20070401

An eight-week, open-label, prospective case series of acamprosate calcium as monotherapy for patients with comorbid anxiety symptoms and alcohol misuse: an evaluation for alcohol sobriety and anxiolysis.

Psychiatry (Edgmont (Pa. : Township)) 20070401

Measuring economic outcomes of alcohol treatment using the Economic Form 90.

Journal of studies on alcohol and drugs 20070301

Emerging approaches to managing alcohol dependence.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

Improving adherence in patients with alcohol dependence: a new role for pharmacists.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

Alcohol dependence and pharmacologic treatment. Introduction.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

Schizophrenia and co-occurring substance use disorder.

The American journal of psychiatry 20070301

Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice.

Addiction biology 20070301

Influence of age at drinking onset on the alcohol deprivation effect and stress-induced drinking in female rats.

Pharmacology, biochemistry, and behavior 20070201

Preclinical and clinical pharmacology of alcohol dependence.

Fundamental & clinical pharmacology 20070201

Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it.

Prescrire international 20070201

[Neurobiological mechanisms and pharmacological treatment options for alcohol craving].

Fortschritte der Neurologie-Psychiatrie 20070101

[Pharmacological relapse prevention in alcohol and tobacco dependence].

Der Internist 20070101

Glutamate-modulating drugs & the treatment of mental disorders.

Journal of psychosocial nursing and mental health services 20070101

Therapeutics for alcoholism: what's the future?

Drug and alcohol review 20070101

Consideration of acamprosate for treatment of amyotrophic lateral sclerosis.

Medical hypotheses 20070101

Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.

Alcohol and alcoholism (Oxford, Oxfordshire) 20070101

Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokers.

Alcohol and alcoholism (Oxford, Oxfordshire) 20070101

Factors predictive of alcohol abstention after resident detoxication among alcoholics followed in an hospital outpatient center.

Gastroenterologie clinique et biologique 20070101

Treatment of tinnitus with acamprosate.

Progress in brain research 20070101

Treating substance abuse in primary care: a demonstration project.

International journal of integrated care 20070101

Somatic configuration: a model for an integrated approach to the understanding of disease.

Substance use & misuse 20070101

The application of machine learning techniques as an adjunct to clinical decision making in alcohol dependence treatment.

Substance use & misuse 20070101

Medication assisted treatment of drug abuse and dependence: global availability and utilization.

Recent patents on anti-infective drug discovery 20070101

Pharmacoprophylaxis of alcohol dependence: Review and update Part I: Pharmacology.

Indian journal of psychiatry 20070101

Pharmacoprophylaxis of alcohol dependence: Review and update Part II: Efficacy.

Indian journal of psychiatry 20070101

Unusual side effects with acamprosate.

Indian journal of psychiatry 20070101

[Drugs against alcohol abuse].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20061214

New pharmacological approaches for the treatment of alcoholism.

Expert opinion on pharmacotherapy 20061201

Trends in the adoption of medications for alcohol dependence.

Journal of clinical psychopharmacology 20061201

Combining psychosocial treatment with pharmacotherapy for alcohol dependence.

Journal of clinical psychopharmacology 20061201

Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations.

Bipolar disorders 20061201

Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms.

Neurotoxicity research 20061201

Acamprosate: a new tool in the battle against alcohol dependence.

Neuropsychiatric disease and treatment 20061201

Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.

Addictive behaviors 20061101

The mechanistic classification of addictive drugs.

PLoS medicine 20061101

Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats.

Biopharmaceutics & drug disposition 20061001

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

Addiction (Abingdon, England) 20061001

Choosing the right medication for the treatment of alcoholism.

Current psychiatry reports 20061001

Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?

Expert opinion on pharmacotherapy 20061001

Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

Pharmacology & therapeutics 20060901

Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.

Alcoholism, clinical and experimental research 20060901

Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.

Neuroscience letters 20060814

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

Journal of psychiatric research 20060801

Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?

Biological psychiatry 20060701

Drug adjuncts for treating alcohol dependence.

Cleveland Clinic journal of medicine 20060701

Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: part I.

Journal of psychiatric practice 20060701

Attenuation of cocaine-induced reinstatement of cocaine conditioned place preference by acamprosate.

Behavioural pharmacology 20060601

[Maintaining abstinence after alcohol detoxification].

La Revue du praticien 20060531

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

JAMA 20060503

What's new in clinical pharmacology and therapeutics.

WMJ : official publication of the State Medical Society of Wisconsin 20060501

Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.

Yonsei medical journal 20060430

A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients.

Alcoholism, clinical and experimental research 20060401

Tinnitus. Overcoming the noise.

Mayo Clinic health letter (English ed.) 20060401

Practical considerations of new drugs: new choices for old problems.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060401

The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.

Journal of psychiatric practice 20060301

Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.

Addiction biology 20060301

N-methyl-D-aspartate and group I metabotropic glutamate receptors are involved in the expression of ethanol-induced sensitization in mice.

Behavioural pharmacology 20060201

New drugs 06, part I.

Nursing 20060201

Alcoholism and pathways to recovery: new survey results on views and treatment options.

MedGenMed : Medscape general medicine 20060104

Alcoholism and suicidal behavior: a clinical overview.

Acta psychiatrica Scandinavica 20060101

Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.

Alcohol and alcoholism (Oxford, Oxfordshire) 20060101

Impact of practitioner's training in the management of alcohol dependence: a quasi-experimental 18-month follow-up study.

Substance abuse treatment, prevention, and policy 20060101

Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler.

Drugs 20060101

Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?

Journal of addictive diseases 20060101

[Treatment and prevention of alcohol-related problems and evidence based medicine].

Casopis lekaru ceskych 20060101

New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence.

European journal of pharmacology 20051205

Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?

Addiction biology 20051201

New alcohol abuse drugs emerging. Anti-craving meds are finally here to treat alcohol dependence, recognized as a disease of the brain.

Health news (Waltham, Mass.) 20051201

Sleep disturbances, psychiatric disorders, and psychotropic drugs.

Dialogues in clinical neuroscience 20051201

Is there evidence for effectiveness of acamprosate in maintaining abstinence in alcohol dependent patients?

Psychiatry (Edgmont (Pa. : Township)) 20051201

Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference.

Neuroscience letters 20051104

Medications for treating alcohol dependence.

American family physician 20051101

The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.

Journal of studies on alcohol 20051101

Acamprosate in the treatment of alcohol dependence.

Expert opinion on pharmacotherapy 20051001

Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats.

European journal of pharmacology 20050927

Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.

Journal of psychiatric research 20050901

The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.

Addiction biology 20050901

Acamprosate.

Nursing times 20050901

Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.

Alcoholism, clinical and experimental research 20050801

A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment.

Pharmacopsychiatry 20050701

Suppression of the HPA axis stress-response: implications for relapse.

Alcoholism, clinical and experimental research 20050701

Drug treatment for alcoholism today.

The Harvard mental health letter 20050701

Combining treatments for alcoholism: why and how?